Welcome to CenterNet's CME testing site for
The Untold Story: Women and Heart Disease .
This continuing educational activity consists of a 1 hour video with a CME post
test and evaluation form.
This activity should take about 1.5 hours to complete. To qualify for credit and
receive a Certificate of Completion, the participant should:
1. review the objectives
2. watch the video
3. complete the viewer evaluation, post test, and CME application which are
all available online at this website.
If you achieve a score of 70% or more, you
will be able to print your CME certificate from this online site.
If you don't manage to achieve a passing score, you are welcome to try again.
If you have any difficulty printing out your certificate, please email
cme@centernet-tv.com with your
problem.
CME credit is available until May 2004 for this program. No credit will be given
after that date.
Good Luck!
Objectives for The Untold Story: Women and Heart
Disease
• Review key statistics on cardiovascular disease in women
• Describe the alarming trends in the prevalence of modifiable risk factors for
cardiovascular disease
• Describe the four National Heart, Lung and Blood Institutes Cardiovascular
Health Performance Goals and the disparities in women’s heart health related to
each of the goals.
• Describe opportunities for integrating preventive cardiology for women at
various stages of the lifecycle into clinical practice.
• Explain ways to integrate the American Heart Association/American College of
Cardiology preventive cardiology guidelines for women into routine office
visits, including screening and counseling related to lifestyle factors and
cardiovascular disease risk factors, and use of pharmacological interventions
• Identify the types of patients to refer to a cardiologist
• Discuss the reasons why diagnosis of coronary heart disease is a greater
challenge in women than in men
• State the signs and symptoms of acute myocardial infarction in women and the
reasons women often delay treatment
• Describe the current standards of medical care for women who are diagnosed
with a myocardial infarction
Faculty Disclosures
|
Name |
Grantee/Research |
Consultant Speakers Bureau |
Advisory Board |
| Sharonne N. Hayes, MD | none | none | none |
| Bruce MacLeod, MD | none | none | none |
| Deborah J. Barbour, MD | none | 1,2,3 | none |
| 1. Bayer 2. Parke Davis 3. Pfizer |
Accreditation Information
The NIH/FAES is accredited by the Accreditation Council for Continuing
Medical Education to sponsor continuing medical education for physicians.
The NIH/FAES designates this educational activity for a maximum of 1.5 hours in
category 1 credit for each program (total of 15 hours for entire series) towards
the AMA Physician’s Recognition Award. Each physician should claim only those
hours of credit actually spent in the educational activity.
This activity has been planned and implemented in accordance with the Essentials
and Standards of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of the National Institutes of Health/Foundation
for Advanced Education in the Sciences (NIH/FAES) and The Association of
Academic Health Centers (AHC). The views presented here
are those of the Roundtable panel members and not necessarily those of
CenterNet, the producer, the Association of Academic Health Centers, the
National Heart, Lung and Blood Institute of the National Institutes of Health,
or any government agency. Neither the National Heart, Lung and Blood Institute
of the National Institutes of Health, nor any other government agency endorse
any particular drug or product. Before using or prescribing any product
discussed in the video, clinicians should consult the full prescribing
information.
References for Further Study
Greenlund KJ, Giles WH, Keenan NL, Croft JB, Casper ML, Matson-Koffman D.
Prevalence of multiple cardiovascular disease risk factors among women in the
United States, 1992 and 1995: the Behavioral Risk Factor Surveillance System. J
Womens Health 1998; 7:1125-33.
Meischke H, Larsen MP, Eisenberg MS. Gender differences in reported
symptoms for acute myocardial infarction: impact on prehospital delay time
interval [see comments]. Am J Emerg Med 1998; 16:363-6.
Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness,
perception, and knowledge of heart disease risk and prevention among women in
the United States. American Heart Association Women's Heart Disease and Stroke
Campaign Task Force [see comments]. Arch Fam Med 2000; 9:506-15.
Penque S, Halm M, Smith M, et al. Women and coronary disease:
relationship between descriptors of signs and symptoms and diagnostic and
treatment course. Am J Crit Care 1998; 7:175-82.
Roberston RM. Women and cardiovascular disease: the risks of
misperception and the need for action. Circulation 2001; 103:2318-2320.
Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in
women. New England Journal of Medicine 1993; 329:247-256.